Cargando…
A serum miRNAs signature for early diagnosis of bladder cancer
BACKGROUND: Bladder cancer accounts for the most common type of urologic malignancy and presents high recurrence rate after surgical resection and adjuvant intravesical therapy. We aim to search for an early diagnostic biomarker in serum for bladder cancer in this study. METHODS: The expression prof...
Autores principales: | Yu, Zuhu, Lu, Chong, Lai, Yongqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980012/ https://www.ncbi.nlm.nih.gov/pubmed/36856518 http://dx.doi.org/10.1080/07853890.2023.2172206 |
Ejemplares similares
-
A novel prognostic signature for clear cell renal cell carcinoma constructed using necroptosis-related miRNAs
por: Yu, Zuhu, et al.
Publicado: (2023) -
Combination of Serum miRNAs with Serum Exosomal miRNAs in Early Diagnosis for Non-Small-Cell Lung Cancer
por: Wu, Qingwei, et al.
Publicado: (2020) -
Identification of a three-miRNA panel in serum for bladder cancer diagnosis by a diagnostic test
por: Li, Rongkang, et al.
Publicado: (2022) -
New Insights in Bladder Cancer Diagnosis: Urinary miRNAs and Proteins
por: Güllü Amuran, Gökçe, et al.
Publicado: (2018) -
A 2 miRNAs-based signature for the diagnosis of atherosclerosis
por: Han, Xiujiang, et al.
Publicado: (2021)